IndraLab
Statements
reach
"In line with the activation of TBK1, treatment of human primary monocytes with the combination of CXCL4 and the TLR8 ligand ORN8L induced a strong increase in CYLD phosphorylation (Fig. 1A), which is the downstream of TBK1 [10, 11]; and TBK1/IKKε can inhibit CYLD deubiquitinase activity by phosphorylation at serine 418 [11–13] (Fig. 1B)."